Test Code MDC2 Movement Disorder, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid
Ordering Guidance
Multiple neurological phenotype-specific autoimmune/paraneoplastic evaluations are available. For more information as well as phenotype-specific testing options, see Autoimmune Neurology Test Ordering Guide.
When more than one evaluation is ordered on the same order number the duplicate will be canceled.
For a list of antibodies performed with each evaluation, see Autoimmune Neurology Antibody Matrix.
Necessary Information
Provide the following information:
-Relevant clinical information
-Ordering healthcare professional’s name, phone number, mailing address, and e-mail address
Specimen Required
Patient Preparation: For optimal antibody detection, collect specimen before starting immunosuppressant medication, corticosteroids, or intravenous immunoglobulin treatment.
Container/Tube: Sterile vial
Preferred: Collection vial number 1
Acceptable: Any collection vial
Specimen Volume: 4 mL
Forms
If not ordering electronically, complete, print, and send a Neurology Specialty Testing Client Test Request (T732) with the specimen.
Useful For
Evaluating patients with suspected paraneoplastic or other autoimmune movement disorders including patients with ataxia, brainstem encephalitis, chorea, dyskinesias, myoclonus, and parkinsonism using spinal fluid specimens
Profile Information
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| MDCI | Movement Disorder Interp, CSF | No | Yes |
| AMPCC | AMPA-R Ab CBA, CSF | No | Yes |
| AMPHC | Amphiphysin Ab, CSF | No | Yes |
| AGN1C | Anti-Glial Nuclear Ab, Type 1 | No | Yes |
| ANN1C | Anti-Neuronal Nuclear Ab, Type 1 | No | Yes |
| ANN2C | Anti-Neuronal Nuclear Ab, Type 2 | No | Yes |
| ANN3C | Anti-Neuronal Nuclear Ab, Type 3 | No | Yes |
| APBIC | AP3B2 IFA, CSF | No | Yes |
| CS2CC | CASPR2-IgG CBA, CSF | No | Yes |
| CRMC | CRMP-5-IgG, CSF | No | Yes |
| DPPCC | DPPX Ab CBA, CSF | No | Yes |
| GABCC | GABA-B-R Ab CBA, CSF | No | Yes |
| GD65C | GAD65 Ab Assay, CSF | Yes | Yes |
| GFAIC | GFAP IFA, CSF | No | Yes |
| GRFIC | GRAF1 IFA, CSF | No | Yes |
| IG5CC | IgLON5 CBA, CSF | No | Yes |
| ITPIC | ITPR1 IFA, CSF | No | Yes |
| KLHCC | KLHL11-IgG CBA, CSF | Yes | Yes |
| LG1CC | LGI1-IgG CBA, CSF | No | Yes |
| MA2EC | Ma2 Ab ELISA, CSF | Yes | Yes |
| GL1IC | mGluR1 Ab IFA, CSF | No | Yes |
| GL5IC | mGluR5 Ab IFA, CSF | No | Yes |
| NCDIC | Neurochondrin IFA, CSF | No | Yes |
| NIFIC | NIF IFA, CSF | No | Yes |
| NMDCC | NMDA-R Ab CBA, CSF | No | Yes |
| PDEIC | PDE10A Ab IFA, CSF | No | Yes |
| PCTRC | Purkinje Cell Cytoplasmc Ab Type Tr | No | Yes |
| PCA1C | Purkinje Cell Cytoplasmic Ab Type 1 | No | Yes |
| PCA2C | Purkinje Cell Cytoplasmic Ab Type 2 | No | Yes |
| SP5IC | Septin-5 IFA, CSF | No | Yes |
| SP7IC | Septin-7 IFA, CSF | No | Yes |
| T46IC | TRIM46 Ab IFA, CSF | No | Yes |
Reflex Tests
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| AGNBC | AGNA-1 Immunoblot, CSF | No | No |
| AINCC | Alpha Internexin CBA, CSF | No | No |
| AMPIC | AMPA-R Ab IF Titer Assay, CSF | No | No |
| AMIBC | Amphiphysin Immunoblot, CSF | No | No |
| AN1BC | ANNA-1 Immunoblot, CSF | No | No |
| AN2BC | ANNA-2 Immunoblot, CSF | No | No |
| DPPTC | DPPX Ab IFA Titer, CSF | No | No |
| GABIC | GABA-B-R Ab IF Titer Assay, CSF | No | No |
| GRFCC | GRAF1 CBA, CSF | No | No |
| GRFTC | GRAF1 IFA Titer, CSF | No | No |
| IG5TC | IgLON5 IFA Titer, CSF | No | No |
| ITPCC | ITPR1 CBA, CSF | No | No |
| ITPTC | ITPR1 IFA Titer, CSF | No | No |
| GL1TC | mGluR1 Ab IFA Titer, CSF | No | No |
| GL1CC | mGluR1 Ab CBA, CSF | No | No |
| NFHCC | NIF Heavy Chain CBA, CSF | No | No |
| NIFTC | NIF IFA Titer, CSF | No | No |
| NFLCC | NIF Light Chain CBA, CSF | No | No |
| NMDIC | NMDA-R Ab IF Titer Assay, CSF | No | No |
| PC1BC | PCA-1 Immunoblot, CSF | No | No |
| PCTBC | PCA-Tr Immunoblot, CSF | No | No |
| AN1TC | ANNA-1 Titer, CSF | No | No |
| AN2TC | ANNA-2 Titer, CSF | No | No |
| AN3TC | ANNA-3 Titer, CSF | No | No |
| APBCC | AP3B2 CBA, CSF | No | No |
| CRMTC | CRMP-5-IgG Titer, CSF | No | No |
| GFACC | GFAP CBA, CSF | No | No |
| GFATC | GFAP IFA Titer, CSF | No | No |
| NCDCC | Neurochondrin CBA, CSF | No | No |
| NCDTC | Neurochondrin IFA Titer, CSF | No | No |
| PC1TC | PCA-1 Titer, CSF | No | No |
| PC2TC | PCA-2 Titer, CSF | No | No |
| PCTTC | PCA-Tr Titer, CSF | No | No |
| PDETC | PDE10A Ab IFA Titer, CSF | No | No |
| SP5CC | Septin-5 CBA, CSF | No | No |
| SP5TC | Septin-5 IFA Titer, CSF | No | No |
| SP7CC | Septin-7 CBA, CSF | No | No |
| SP7TC | Septin-7 IFA Titer, CSF | No | No |
| T46CC | TRIM46 Ab CBA, CSF | No | No |
| T46TC | TRIM46 Ab IFA Titer, CSF | No | No |
| AGNTC | AGNA-1 Titer, CSF | No | No |
| K11TC | KLHL11 Ab IFA Titer, CSF | No | No |
| MP1BC | MAP1B Immunoblot, CSF | No | No |
| GL5CC | mGluR5 Ab CBA, CSF | No | No |
| GL5TC | mGluR5 Ab IFA Titer, CSF | No | No |
| APHTC | Amphiphysin Ab Titer, CSF | No | No |
| CRMWC | CRMP-5-IgG Western Blot, CSF | No | No |
| APBTC | AP3B2 IFA Titer, CSF | No | No |
Method Name
AGN1C, AMPHC, ANN1C, ANN2C, ANN3C, APBIC, CRMC, GFAIC, GL1IC, GL5IC, GRFIC, ITPIC, NCDIC, NIFIC, PCA1C, PCA2C, PCTRC, PDEIC, SP5IC, SP7IC, T46IC, AGNTC, AMPIC, AN1TC, AN2TC, AN3TC, APHTC, CRMTC, DPPTC, GABIC, GFATC, GL1TC, GL5TC, GRFTC, IG5TC, ITPTC, K11TC, NCDTC, NIFTC, NMDIC, PC1TC, PC2TC, PCTTC, PDETC, SP5TC, SP7TC, T46TC: Indirect Immunofluorescence Assay (IFA)
AMPCC, CS2CC, DPPCC, GABCC, IG5CC, KLHCC, LG1CC, NMDCC, AINCC, APBCC, GFACC, GL1CC, GL5CC, GRFCC, ITPCC, NCDCC, NFHCC, NFLCC, SP5CC, SP7CC, T46CC: Cell Binding Assay (CBA)
MA2EC: Enzyme-Linked Immunosorbent Assay (ELISA)
CRMWC: Western Blot (WB)
GD65C: Radioimmunoassay (RIA)
AGNBC, AMIBC, AN1BC, AN2BC, MP1BC, PC1BC, PCTBC: Immunoblot (IB)
MDCI: Technical Interpretation
Reporting Name
Movement, Autoimm/Paraneo, CSFSpecimen Type
CSFSpecimen Minimum Volume
2 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| CSF | Refrigerated (preferred) | 28 days |
| Frozen | 28 days | |
| Ambient | 72 hours |
Reject Due To
| Gross hemolysis | Reject |
| Gross lipemia | Reject |
| Gross icterus | Reject |
Clinical Information
Autoimmune movement disorders encapsulate a large and diverse group of neurologic disorders occurring either in isolation or accompanying more diffuse autoimmune encephalitic illnesses.
The full range of movement phenomena has been described, and, as they often occur in adults, many of the presentations can mimic neurodegenerative disorders, such as autoimmune chorea mimicking Huntington disease. Disorders may be ataxic, hypokinetic (parkinsonism), or hyperkinetic (myoclonus, chorea other dyskinetic disorders). Associated disorders may fall under the rubric of brainstem encephalitis.
The autoantibody targets are diverse and include neuronal surface proteins, such as leucine-rich, glioma-inactivated 1 (LGI1), as well as antibodies reactive with intracellular antigens (such as Purkinje cell cytoplasmic antibody-1 [PCA-1]) that are markers of a central nervous system process mediated by CD8+ cytotoxic T cells.
In some instances (such as PCA-1 autoimmunity), antibodies detected in serum and cerebrospinal fluid can be indicative of a paraneoplastic cause and may direct the cancer search. In other instances (such as 65-kDa isoform of glutamic acid decarboxylase [GAD65] autoimmunity), a paraneoplastic cause is very unlikely, and early treatment with immunotherapy may promote improvement or recovery.
Reference Values
|
Test ID |
Reporting name |
Methodology* |
Reference value |
|
MDCI |
Movement Disorder Interp, CSF |
Technical interpretation |
Interpretive report |
|
AMPCC |
AMPA-R Ab CBA, CSF |
CBA |
Negative |
|
AMPHC |
Amphiphysin Ab, CSF |
IFA |
Negative |
|
AGN1C |
Anti-Glial Nuclear Ab, Type 1 |
IFA |
Negative |
|
ANN1C |
Anti-Neuronal Nuclear Ab, Type 1 |
IFA |
Negative |
|
ANN2C |
Anti-Neuronal Nuclear Ab, Type 2 |
IFA |
Negative |
|
ANN3C |
Anti-Neuronal Nuclear Ab, Type 3 |
IFA |
Negative |
|
APBIC |
AP3B2 IFA, CSF |
IFA |
Negative |
|
CS2CC |
CASPR2-IgG CBA, CSF |
CBA |
Negative |
|
CRMC |
CRMP-5-IgG, CSF |
IFA |
Negative |
|
DPPCC |
DPPX Ab CBA, CSF |
CBA |
Negative |
|
GABCC |
GABA-B-R Ab CBA, CSF |
CBA |
Negative |
|
GD65C |
GAD65 Ab Assay, CSF |
RIA |
≤0.02 nmol/L |
|
GFAIC |
GFAP IFA, CSF |
IFA |
Negative |
|
GRFIC |
GRAF1 IFA, CSF |
IFA |
Negative |
|
IG5CC |
IgLON5 CBA, CSF |
CBA |
Negative |
|
ITPIC |
ITPR1 IFA, CSF |
IFA |
Negative |
|
KLHCC |
KLHL11-IgG CBA, CSF |
CBA |
Negative |
|
LG1CC |
LGI1-IgG CBA, CSF |
CBA |
Negative |
|
MA2EC |
Ma2 Ab ELISA, CSF |
ELISA |
Negative |
|
GL1IC |
mGluR1 Ab IFA, CSF |
IFA |
Negative |
|
GL5IC |
mGluR5 Ab IFA, CSF |
IFA |
Negative |
|
NCDIC |
Neurochondrin IFA, CSF |
IFA |
Negative |
|
NIFIC |
NIF IFA, CSF |
IFA |
Negative |
|
NMDCC |
NMDA-R Ab CBA, CSF |
CBA |
Negative |
|
PDEIC |
PDE10A Ab IFA, CSF |
IFA |
Negative |
|
PCTRC |
Purkinje Cell Cytoplasmc Ab Type Tr |
IFA |
Negative |
|
PCA1C |
Purkinje Cell Cytoplasmic Ab Type 1 |
IFA |
Negative |
|
PCA2C |
Purkinje Cell Cytoplasmic Ab Type 2 |
IFA |
Negative |
|
SP5IC |
Septin-5 IFA, CSF |
IFA |
Negative |
|
SP7IC |
Septin-7 IFA, CSF |
IFA |
Negative |
|
T46IC |
TRIM46 Ab IFA, CSF |
IFA |
Negative |
Reflex Information:
|
Test ID |
Reporting name |
Methodology* |
Reference value |
|
AGNBC |
AGNA-1 Immunoblot, CSF |
IB |
Negative |
|
AGNTC |
AGNA-1 Titer, CSF |
IFA |
<1:2 |
|
AINCC |
Alpha Internexin CBA, CSF |
CBA |
Negative |
|
AMPIC |
AMPA-R Ab IF Titer Assay, CSF |
IFA |
<1:2 |
|
APHTC |
Amphiphysin Ab Titer, CSF |
IFA |
<1:2 |
|
AMIBC |
Amphiphysin Immunoblot, CSF |
IB |
Negative |
|
AN1BC |
ANNA-1 Immunoblot, CSF |
IB |
Negative |
|
AN1TC |
ANNA-1 Titer, CSF |
IFA |
<1:2 |
|
AN2BC |
ANNA-2 Immunoblot, CSF |
IB |
Negative |
|
AN2TC |
ANNA-2 Titer, CSF |
IFA |
<1:2 |
|
AN3TC |
ANNA-3 Titer, CSF |
IFA |
<1:2 |
|
APBCC |
AP3B2 CBA, CSF |
CBA |
Negative |
|
CRMTC |
CRMP-5-IgG Titer, CSF |
IFA |
<1:2 |
|
CRMWC |
CRMP-5-IgG Western Blot, CSF |
WB |
Negative |
|
DPPTC |
DPPX Ab IFA Titer, CSF |
IFA |
<1:2 |
|
GABIC |
GABA-B-R Ab IF Titer Assay, CSF |
IFA |
<1:2 |
|
GFACC |
GFAP CBA, CSF |
CBA |
Negative |
|
GFATC |
GFAP IFA Titer, CSF |
IFA |
<1:2 |
|
GRFCC |
GRAF1 CBA, CSF |
CBA |
Negative |
|
GRFTC |
GRAF1 IFA Titer, CSF |
IFA |
<1:2 |
|
IG5TC |
IgLON5 IFA Titer, CSF |
IFA |
<1:2 |
|
ITPCC |
ITPR1 CBA, CSF |
CBA |
Negative |
|
ITPTC |
ITPR1 IFA Titer, CSF |
IFA |
<1:2 |
|
K11TC |
KLHL11 Ab IFA Titer, CSF |
IFA |
<1:2 |
|
MP1BC |
MAP1B Immunoblot, CSF |
IB |
Negative |
|
GL1CC |
mGluR1 Ab CBA, CSF |
CBA |
Negative |
|
GL1TC |
mGluR1 Ab IFA Titer, CSF |
IFA |
<1:2 |
|
GL5CC |
mGluR5 Ab CBA, CSF |
CBA |
Negative |
|
GL5TC |
mGluR5 Ab IFA Titer, CSF |
IFA |
<1:2 |
|
NCDCC |
Neurochondrin CBA, CSF |
CBA |
Negative |
|
NCDTC |
Neurochondrin IFA Titer, CSF |
IFA |
<1:2 |
|
NFHCC |
NIF Heavy Chain CBA, CSF |
CBA |
Negative |
|
NIFTC |
NIF IFA Titer, CSF |
IFA |
<1:2 |
|
NFLCC |
NIF Light Chain CBA, CSF |
CBA |
Negative |
|
NMDIC |
NMDA-R Ab IF Titer Assay, CSF |
IFA |
<1:2 |
|
PC1BC |
PCA-1 Immunoblot, CSF |
IB |
Negative |
|
PC1TC |
PCA-1 Titer, CSF |
IFA |
<1:2 |
|
PC2TC |
PCA-2 Titer, CSF |
IFA |
<1:2 |
|
PCTBC |
PCA-Tr Immunoblot, CSF |
IB |
Negative |
|
PCTTC |
PCA-Tr Titer, CSF |
IFA |
<1:2 |
|
PDETC |
PDE10A Ab IFA Titer, CSF |
IFA |
<1:2 |
|
SP5CC |
Septin-5 CBA, CSF |
CBA |
Negative |
|
SP5TC |
Septin-5 IFA Titer, CSF |
IFA |
<1:2 |
|
SP7CC |
Septin-7 CBA, CSF |
CBA |
Negative |
|
SP7TC |
Septin-7 IFA Titer, CSF |
IFA |
<1:2 |
|
T46CC |
TRIM46 Ab CBA, CSF |
CBA |
Negative |
|
T46TC |
TRIM46 Ab IFA Titer, CSF |
IFA |
<1:2 |
*Methodology abbreviations:
Cell-binding assay (CBA)
Enzyme-linked immunosorbent assay (ELISA)
Immunoblot (IB)
Indirect immunofluorescence assay (IFA)
Radioimmunoassay (RIA)
Western blot (WB)
Day(s) Performed
Profile tests: Monday through Sunday; Reflex tests: Varies
Report Available
8 to 12 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
86255 x28
83516
86341
0432U
84182 AGNBC (if appropriate)
86256 AGNTC (if appropriate)
86255 AINCC (if appropriate)
86256 AMPIC (if appropriate)
86256 APHTC (if appropriate)
84182 AMIBC (if appropriate)
84182 AN1BC (if appropriate)
86256 AN1TC (if appropriate)
84182 AN2BC (if appropriate)
86256 AN2TC (if appropriate)
86256 AN3TC (if appropriate)
86255 APBCC (if appropriate)
86256 CRMTC (if appropriate)
84182 CRMWC (if appropriate)
86256 DPPTC (if appropriate)
86256 GABIC (if appropriate)
86255 GFACC (if appropriate)
86256 GFATC (if appropriate)
86255 GRFCC (if appropriate)
86256 GRFTC (if appropriate)
86256 IG5TC (if appropriate)
86255 ITPCC (if appropriate)
86256 ITPTC (if appropriate)
86256 K11TC (if appropriate)
84182 MP1BC (if appropriate)
86255 GL1CC (if appropriate)
86256 GL1TC (if appropriate)
86255 GL5CC (if appropriate)
86256 GL5TC (if appropriate)
86255 NCDCC (if appropriate)
86256 NCDTC (if appropriate)
86255 NFHCC (if appropriate)
86256 NIFTC (if appropriate)
86255 NFLCC (if appropriate)
86256 NMDIC (if appropriate)
84182 PC1BC (if appropriate)
86256 PC1TC (if appropriate)
86256 PC2TC (if appropriate)
84182 PCTBC (if appropriate)
86256 PCTTC (if appropriate)
86256 PDETC (if appropriate)
86255 SP5CC (if appropriate)
86256 SP5TC (if appropriate)
86255 SP7CC (if appropriate)
86256 SP7TC (if appropriate)
86255 T46CC (if appropriate)
86256 T46TC (if appropriate)